Last reviewed · How we verify

NCT06291441

Women Urinary Incontinence Prevalence Study (WUIPS)

Recruiting now Last updated 19 September 2024
What this trial tests

trial testing No intervention in Female Urinary Incontinence in 449 participants. Currently enrolling.

Timeline
3 July 2024
Primary endpoint
31 December 2025
31 December 2025

Quick facts

Lead sponsorIRCCS San Raffaele
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment449
Start date3 July 2024
Primary completion31 December 2025
Estimated completion31 December 2025
Sites4 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS San Raffaele — full company profile →

Who can join

Adults 40 to 65, female only, with Female Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this multicenter prospective and prevalence observational study is to punctually investigate and describe prevalence, predictors, quality of life and costs of Urinary Incontinence (UI) among female patients, female caregivers and female personnel in four hospitals in Northern Italy: San Raffaele hospital in Milan, San Raffaele Turro hospital in Milan, Zingonia Policlinico San Marco (BG) and Policlinico San Pietro in Ponte San Pietro (BG).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Female urinary incontinence in middle-aged women in four hospitals in Northern Italy: A multicentre prevalence study.
    Trapani S, De Angeli G, Villa G, Bagnato E, et al · · 2024 · PMID 39415876 · DOI 10.1016/j.mex.2024.102987

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Female Urinary Incontinence

Currently open trials in the same condition.

Other IRCCS San Raffaele trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06291441.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing